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Sox6 is a member of the Sox transcription factor family that is defined by the conserved high mobility group (HMG)
DNA binding domain, first described in the testis determining gene, Sry. Previous studies have suggested that Sox6
plays a role in the development of the central nervous system, cartilage, and muscle. In the Sox6-deficient mouse,
p100H, ey globin is persistently expressed, and increased numbers of nucleated red cells are present in the fetal
circulation. Transfection assays in GM979 (erythroleukemic) cells define a 36–base pair region of the ey proximal
promoter that is critical for Sox6 mediated repression. Electrophoretic mobility shift assay (EMSA) and chromatin
immunoprecipitation (ChIP) assays demonstrate that Sox6 acts as a repressor by directly binding to the ey promoter.
The normal expression of Sox6 in wild-type fetal liver and the ectopic expression of ey in p100H homozygous fetal liver
demonstrate that Sox6 functions in definitive erythropoiesis. The present study shows that Sox6 is required for
silencing of ey globin in definitive erythropoiesis and suggests a role for Sox6 in erythroid cell maturation. Thus, Sox6
regulation of ey globin might provide a novel therapeutical target in the treatment of hemoglobinopathies such as
sickle cell anemia and thalassemia.
Citation: Yi Z, Cohen-Barak O, Hagiwara N, Kingsley PD, Fuchs DA, et al. (2006) Sox6 directly silences epsilon globin expression in definitive erythropoiesis. PLoS Genet 2(2): e14.
Introduction
Sry type HMG box (Sox6) is a member of the Sox
transcription factor family characterized by the conserved
high mobility group (HMG) domain, consisting of 79 amino
acids involved in DNA recognition and binding [1]. Sox
transcription factors bind to the minor groove of DNA and
cause a 708–858 bend of the DNA that leads to local
conformational changes [2,3], while most other transcription
factors target the major groove of DNA [4]. Therefore, Sox
proteins may perform part of their function as architectural
proteins by organizing local chromatin structure and assem-
bling other DNA-bound transcription factors into biolog-
ically active, sterically defined multiprotein complexes. Sox6
has been reported to be able to act as either an activator or a
repressor, depending on its interactors and its target
promoter context [5,6]. Intriguingly, Sox6 has also been
shown to act as a general splicing factor that participates in
pre-mRNA splicing [7]. Depletion of Sox6 in HeLa cell
extracts blocked splicing of multiple substrates, and expres-
sion of the HMG domain of either Sox6, Sox9, or Sry in the
extracts restored splicing, indicating functional overlap of
these proteins [7]. Regardless of how Sox6 functions in
regulating gene expression, previous studies have demon-
strated that Sox6 is an important regulatory molecule that
plays a role in the development of the central nervous system
[8–11], cartilage [6,12,13], and muscle [14,15]. A Sox6-null
mutant mouse (p100H) has previously been identified in our
laboratory [14]. Mice homozygous for p100H show delayed
growth, develop myopathy and arterioventricular heart block,
and die within 2 wk after birth [14]. The p100H mutant allele is
associated with a Chromosome 7 inversion that disrupts both
the p gene and the Sox6 gene (and no other gene within 50,000
nucleotides of the chromosomal breakpoints) [14]. Because
the p gene functions solely in pigmentation [16], the Sox6
transcription factor is implicated in all other phenotypes.
Among the HMG box proteins distantly related to Sry (the
first member identified of the Sox transcription factor family)
that similarly bind to the minor groove and bend DNA, but
without sequence specificity, are the ubiquitously expressed
HMG1 and HMG2 proteins [17]. Modulation of DNA
structure by these and other HMG proteins can mediate
long-range enhancer function on both DNA and chromatin-
assembled genes by bringing together distant regions of DNA
and associated factors. Specifically, HMG proteins have been
shown to modulate b-globin genes [18–21].
The mouse b-globin genes fey, bh1, b-major, and b-minorg
are clustered on Chromosome 7 and they are highly
homologous to their human counterparts in organizational
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structure and function [22]. High-level expression of these
genes requires a regulatory element, the locus control region
that is characterized by a set of nuclease hypersensitive sites
spread over 25 kb located 59 of the ey gene [23]. The b-globin
genes are expressed in a tissue- and development-specific
fashion. In mice, erythropoiesis originates in the embryonic
yolk sac where primitive erythroid cells express ey and bh-1
globins [22]. At 11.5 d post coitus (dpc), erythropoiesis shifts
to the fetal liver where definitive erythroid cells express adult
b globins (b major and minor) [22]. The ey gene is silenced in
definitive erythroid cells. The mechanism of silencing of its
human counterpart, e globin, has been studied extensively. In
definitive erythropoiesis, e is activated and silenced autono-
mously [24,25], although in primitive erythropoiesis e also
appears to be regulated competitively [26]. The c-globin to
adult b-globin switch is controlled by promoter competition
for the LCR [24,25].
All the elements responsible for silencing the e globin gene
are within the e gene or in adjacent sequences [27], suggesting
that silencing is primarily gene autonomous. Using promoter
deletion analyses in transgenic mouse models and cell
transfection assays, multiple DNA elements important to
the silencing process have been previously identified in both
the proximal and the distal e gene promoter [27]. Their
corresponding transcription factors, such as GATA-1, YY-1,
COUP-TF, and DRED have been identified and shown to
directly bind to these DNA elements (as part of protein
complexes) to regulate e silencing [27]. Thus, it appears that
the silencing of the e gene involves a complicated network of
multiple cis elements and transacting proteins.
In addition to playing an important role in the develop-
ment of the central nervous system [8–11], cartilage [6,12,13],
and muscle [14,15], it was shown that Sox6 is upregulated in
long-term hematopoiesis stem cells (LT-HSC) compared with
multipotent progenitors of adult mouse bone marrow lineage
[28]. In this study, we describe that Sox6 also exerts
pleiotropic effects on erythropoiesis. These effects include
delayed maturation of erythrocytes (that normally enucleate
prior to entering the bloodstream [27]) and higher expression
of embryonic globin genes. The most extreme effect is the
persistence of high expression of the embryonic ey globin
gene. Here we describe and characterize the effects of Sox6 on
the ey globin gene. We show that Sox6 binds to the proximal
promoter of ey globin and represses its transcription. In wild-
type (WT) mice, Sox6 is not expressed in yolk sac blood
islands, but is expressed in fetal liver, the opposite expression
pattern of ey globin. In the absence of Sox6, ey globin is
ectopically expressed in the fetal liver, demonstrating that
Sox6 functions in definitive erythropoiesis.
Results
Persistent Expression of the Embryonic Globin, ey, in Sox6-
Deficient Mice
The ey globin gene was initially identified as an upregulated
transcript in the p100H mouse using subtractive hybridization
to identify Sox6 downstream targets. This initial observation
was confirmed in an independent knock-out allele of Sox6
[13] using real-time polymerase chain reaction (PCR) (un-
published data). Real-time PCR was used to quantitate the
expression levels of other globin genes in p100H mutant and
WT mouse livers at two developmental stages, 15.5 dpc and
18.5 dpc. As shown in Figure 1, the ey gene is expressed at
high levels at both time points in mutant mice, in contrast to
the decline in expression observed in WT mice. No difference
was seen between WT and heterozygous mice (unpublished
data). Interestingly, the expression levels of the other two
embryonic globin genes (f and bh1) are also higher in p100H
homozygous mice, compared with WT mice, but to a much
lesser extent than seen for ey globin at 18.5 dpc (Figure 1).
Moreover, the expression level of adult b globin is also
somewhat higher in p100H homozygous mice than in WT mice
at 18.5 dpc (Figure 1). Perinatal lethality of mutant mice
(presumably from the heart defect [14]) precludes us from
evaluating postnatal globin expression. The graphs in Figure
1 illustrate real time PCR results that were performed in
triplicate (standard deviation of the data is shown by error
bars). Because all of the assays were performed at the same
time with the same internal control, the levels shown are
relative levels and are thus comparable across all samples and
are in agreement with previously published results for WT
fetal mice [29]. We note that the level of ey expression in the
livers of 15.5 dpc and 18.5 dpc homozygous mutant mice is
statistically equivalent to the level of bmaj/min expression in
the livers of 15.5 dpc and 18.5 dpc homozygous WT mice.
Transfection Studies Using GM979 Cells Indicate That
Sox6 Directly Represses the ey Gene Promoter at the
Transcriptional Level
Real-time PCR assays (Figure 1) measure steady-state levels
of ey mRNA, not transcriptional activity of the ey promoter.
To investigate whether Sox6 directly acts on the ey gene
promoter at the transcriptional level, we used an in vitro
transient transfection assay and GM979 cells, a murine
erythroleukemic cell line that expresses both ey and adult
beta globins [30]. We generated an ey promoter reporter
construct (E-Luc) by fusing a micro-LCR (lLCR) element (2.5
kb) [31] to the ey proximal promoter (2.2 kb), followed by the
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Synopsis
Beta-globin gene switching—the transition from embryonic to fetal
to adult synthesis of specific globin chains—results in hemoglobins
with different affinity for oxygen. This system is a longstanding
paradigm for developmental biology and is directly relevant to
human disease, since small amounts of normal embryonic or fetal
beta-globins can ‘‘balance’’ the detrimental effect of abnormal or
missing adult globins in diseases such as sickle cell anemia and beta-
thalassemia.
In the current study, the transcription factor Sox6 was identified as a
novel and crucial silencing factor of epsilon (embryonic) globin
through a somewhat serendipitous pathway. The authors had
previously identified a chromosomal inversion, p100H, by virtue of its
effect on the pink-eyed dilution gene and found that the same
inversion also disrupts the Sox6 gene. Using p100H mutant mice as a
tool for identifying downstream targets of Sox6, the authors
discovered that epsilon-globin levels were dramatically elevated,
paving the way for a series of molecular genetic experiments
demonstrating that Sox6 directly binds to and normally inhibits
transcription from the epsilon-globin gene promoter. This work
provides fundamental new insights into regulation of globin gene
transcription during development, and provides new clues for
manipulating globin gene transcription as an approach to treat
human blood diseases.
luciferase reporter gene, as shown in Figure 2A (detailed in
Materials and Methods). Overexpression of Sox6 in GM979
cells by transient transfection leads to a dosage-dependent
repression of E-Luc reporter activity (Figure 2B). In contrast,
overexpression of a truncated Sox6 protein that lacks its HMG
domain [32] (similar to the p100H mouse allele) fails to repress
E-Luc activity (Figure 2B). These data indicate that Sox6 acts
to repress the ey promoter at the transcriptional level.
Sox6 has been shown to act as a repressor and to interact
with a widely expressed co-repressor, CtBP2, on the fgf-3
promoter [5]. CtBP2 is expressed in GM979 cells (unpublished
data). To investigate whether the interaction with CtBP2 is
Figure 1. Real-Time PCR of Globin Genes
The levels of expression of ey, bh1, zeta, and bmaj/min were measured at 15.5 dpc and 18.5 dpc in homozygous WT and p100H mutant littermates by
real-time PCR (see Materials and Methods). Relative expression levels in the livers of each genotype are graphed for each globin gene (performed in
triplicate and normalized with GAPDH). Standard deviation is indicated by bars.
DOI: 10.1371/journal.pgen.0020014.g001
Figure 2. The Effect of Sox6 on the ey Promoter
(A) Constructs of the ey promoter reporter (E-luc) and Sox6 overexpression vector. The E-luc reporter construct consists of a 2.5-kb lLCR element, a 2.2-
kb ey proximal promoter, and the luciferase reporter in the pGL-3 basic plasmid (see Materials and Methods). Sox6 expression is driven by the CMV
promoter.
(B) Sox6 represses ey promoter activity in a dosage-dependent manner. In GM979 cells, the E-Luc ey promoter reporter construct was co-transfected (1)
without overexpression of Sox6; (2–4) with increasing amounts of CMV-Sox6 overexpression vector; (5) with a truncated version of Sox6 that lacks its
HMG domain; (6) with a mutant version of Sox6 (L386H) that has previously been shown to abolish interaction with CtBP2; or (7) with an empty reporter
plasmid (without ey promoter and lLCR element).
(C) Promoter deletion analyses to delimit the critical sequence. The 2.2-kb proximal promoter or deletions of it, as indicated on the left (numbering
relative to þ1 ¼ the transcription start site of ey globin, see Materials and Methods), were engineered in reporter constructs as in (A) and were
transfected along with CMV driven Sox6 to GM979 cells (see Materials and Methods for details). The relative repression by Sox6 on the activity of the
different reporter constructs is shown. All experiments were done in triplicate.
DOI: 10.1371/journal.pgen.0020014.g002
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required for Sox6 repression of the ey promoter, we
introduced a point mutation (L386H) in the Sox6 protein
that has been previously reported to be sufficient to abolish
Sox6-CtBP2 interaction [5]. This amino acid change is not in
the HMG DNA binding domain. However, this mutant
version of Sox6 retains the ability to repress the ey promoter
in the transfection assay (Figure 2B), indicating that Sox6
represses the ey promoter in a CtBP2-independent manner.
Deletion analysis of the ey promoter, as shown in Figure 2C,
defined a region (63 to 37) within the ey proximal
promoter that is critical for Sox6 repression. Analysis of this
short region reveals two Sox/Sox6 consensus binding sites [5]
(Figure 3A).
EMSA and ChIP Assays Show that Sox6 Directly Binds to
the ey Promoter
Sox6 might repress the ey promoter, either through direct
physical contact with the promoter or by regulating
intermediates affecting the ey promoter. To investigate
whether Sox6 is directly associated with the ey promoter,
we first performed electrophoretic mobility shift assays
(EMSA) using a c-Myc-tagged Sox6 in a reticulocyte lysate-
based transcription/translation in vitro system. The probes
used are listed in Figure 3A. The 36–base pair (bp) WT probe
corresponds to the critical region of the ey promoter defined
in our promoter deletion analyses. This probe contains two
consensus Sox/Sox6 binding sites. Also included in our EMSA
are three mutated probes that are, either truncated (M1), or
mutated (M2 and M3) in Sox/Sox6 binding sites (Figure 3A).
Sox6 is able to physically associate with the 36-bp region
(Figure 3B) within the ey promoter defined by the deletion
analysis experiments (Figure 2C). The 36-bp probe was shifted
by the tagged Sox6 protein. Moreover, both c-Myc and Sox6
antibodies supershift the band, indicating that the binding is
Sox6-specific. To rule out the possibility that the c-Myc tag
itself binds to the probe, an HA-tagged Sox6 was used in
another EMSA that confirmed these results (Figure 3C).
Next, nuclear extracts from MEL cells were used in EMSA
employing the same 36-bp probe. MEL cells, a murine
erythroleukemic cell line, express adult b globins, but not ey
[33]. Sox6 directly binds to this DNA sequence in MEL cells
(Figure 3D). The intact consensus Sox/Sox6 binding sites of
the DNA probe are required for the binding, as shown in the
competition assay (Figure 3E). Ablation of putative Sox/Sox6
binding sites (M1 and M3) abolish their ability to compete in
EMSA (Figure 3E). The M2 mutant probe may compete
partially with WT binding.
To investigate the functional significance of the intact Sox/
Sox6 binding sites, the ey promoter reporter constructs with
mutagenized Sox/Sox6 binding sites were co-transfected with
the Sox6 overexpression vector into GM979 cells. Consistent
with the EMSA results, the mutant ey promoter reporter
constructs (with either one or both Sox/Sox6 binding sites
mutagenized) do not result in significant promoter repression
in transfection studies (Figure 3F). Thus, both sites are
required for maximal repression of ey by Sox6, but not to the
same degree.
We also tested whether Sox6 binds to the ey promoter in
vivo using chromatin immunoprecipitation (ChIP) (Figure 4).
Figure 3. Analysis of the Minimal Region (36 bp) of the Proximal ey Promoter Responsive to Sox6
(A) The sequence of the 36-bp fragment and its mutant versions used in EMSA. The WT 36-bp DNA sequence (63 to28) of the ey globin proximal
promoter contains two Sox/Sox6 consensus binding sites, shown in bold underline. Versions with truncation of this sequence (M1) or mutation of one
of the two consensus binding sites (M2 and M3) are also shown.
(B) EMSA with c-Myc-tagged Sox6. EMSA was performed using the 36-bp radio-labeled WT probe (as shown in (A)) and c-Myc tagged Sox6 translated in
vitro using reticulocyte lysate (see Materials and Methods). Lane 1: radio-labeled free probe (run out of the gel); Lane 2: no competition, no antibody;
Lane 3: competition with 200-fold excess cold probe, no antibody; Lane 4: no competition, c-Myc antibody (producing a supershift); Lane 5: no
competition, Sox6 antibody (producing a supershift); Lane 6: no competion, no antibody using in vitro translated vector containing c-Myc, but not Sox6.
(C) EMSA with HA-tagged Sox6. EMSA was performed similarly as in (B) using HA-tagged Sox6 translated in vitro. Lane 1: radio-labeled free probe (run
out of the gel); Lane 2: no competition, no antibody; Lane 3: competition with 200-fold excess cold probe, no antibody; Lane 4: no competition, HA
antibody (producing a supershift).
(D) EMSA using MEL cell nuclear extracts and the 36-bp WT probe. Lane 1: radio-labeled free probe (run out of the gel); Lane 2: no competition, no
antibody; Lane 3: competition with 200-fold excess cold probe, no antibody; Lane 4: no competition, Sox6 antibody (producing a supershift).
(E) EMSA with c-Myc-tagged Sox6, WT and mutant versions of the 36-bp fragment in competition. EMSA was performed using the radio-labeled 36-bp
WT probe and the c-Myc tagged Sox6 translated in vitro. Lane 1: radio-labeled free probe; Lane 2: no competition, no antibody. Competition was
performed using 200-fold excess cold probes corresponding to WT (Lane 3), M1 (Lane 4), M2 (Lane 5), and M3 (Lane 6).
(F) Both consensus Sox/Sox6 binding sites are required for Sox6 responsiveness. GM979 cells were transfected with a reporter construct (Figure 2A)
containing63 toþ45 of the ey proximal promoter together with the CMV-Sox6 overexpression vector. Mutations of the consensus binding sites were
also tested (M3, M2, M2 plus M3, see (A)). The fold repression of Sox6 with the WT or mutant constructs is shown. The baseline activities of the
mutagenized reporter constructs are comparable to the WT construct.
DOI: 10.1371/journal.pgen.0020014.g003
Figure 4. ChIP Assay
MEL cells (A) and 15.5-dpc fetal liver cells (B) were treated as detailed in
Materials and Methods. 10% of the sample was saved as total input (Inp);
remaining samples were divided: plus Sox6 antibody (Abþ), minus Sox6
antibody (Ab), as well as no DNA (DNA) and normal rabbit IgG (IgG)
that served as negative controls. Other controls for these experiments
included PCR within the promoter of the a-globin gene and intron 24 of
the p gene. Both were negative (unpublished data). PCR was carried out
using primer pairs flanking the Sox/Sox6 binding sites (see Material and
Methods) of the ey proximal promoter. For all reactions, we used 2 ll of
immuno-precipitated DNA and 2 ll of 1/100 total input. Semiquantita-
tive PCR was done within the exponential range. Multiple independent
experiments were done.
DOI: 10.1371/journal.pgen.0020014.g004
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The Sox6-containing complex was immunoprecipitated from
MEL cells or from liver cells of 15.5 dpc WT mice using Sox6
antibody. Figure 4 shows that the ey proximal promoter is
readily immunoprecipitated with Sox6 antibody in both MEL
cells and liver cells. Normal IgG was used as a negative control
(Figure 4A). The above data (Figures 3 and 4) clearly indicate
that Sox6 acts as a repressor of the ey gene by directly binding
to the ey promoter, probably as a dimer.
The Persistent Expression of ey Globin in Sox6-Deficient
Mice Is Due to a Defect in the ey-Gene–Silencing
Mechanism in Definitive Erythroid Cells
Normally, the ey globin gene is exclusively expressed in
primitive erythrocytes and silenced in definitive erythrocytes.
To determine whether the persistent expression of ey globin
is due to residual primitive erythrocytes or is due to ectopic
expression of ey globin in definitive erythrocytes, we
examined the spatial pattern of ey globin transcripts in
mouse embryos by in situ hybridization (Figure 5). As
expected, ey globin is not expressed in the WT 14.5-dpc
liver, the site of definitive erythropoiesis in the fetus. In
contrast, abundant ectopic ey mRNA expression is seen in the
liver of 14.5-dpc mutants (Figure 5 A–D). However, the
expression of bmaj/min globin is equally abundant in both
WT and p100H mutant mice (Figure 5 E and F). These data
demonstrate that the persistent high levels of ey are due to
ectopic expression in the definitive erythroid cells that
mature in the fetal liver, suggesting that there is an intrinsic
defect of the ey silencing mechanism in Sox6-null mice.
The Expression Pattern of Sox6 Suggests a Role in
Definitive Erythropoiesis
The observation that Sox6-deficient mice ectopically
express ey globin in liver, where definitive erythroid cells
mature, suggests that Sox6 is an important regulator in
definitive erythropoiesis. To determine the temporal and
spatial expression pattern of Sox6, Northern blot and in situ
hybridization assays were employed. As shown in Figure 6A,
Sox6 is detectable by Northern blot beginning at 10.5 dpc,
coincident with the temporal onset of definitive erythropoi-
esis in the liver. Furthermore, in situ hybridization shows that
Sox6 is highly transcribed in 12.5-dpc liver, but not in yolk sac
blood islands at 7.5 dpc (Figure 6B). Therefore, Sox6
expression is temporally and spatially coincident with
definitive, but not primitive, erythropoiesis. These data,
taken together with the observation that ey globin is highly
expressed in the liver cells of 14.5-dpc p100H mutant mice
(Figure 5), demonstrate that Sox6 functions in definitive
erythropoiesis.
Mutant p100H Mice Have Higher Numbers of Nucleated
Red Cells
Among the other Sox6 effects in erythropoiesis, we have
noticed that there are more nucleated red blood cells
circulating in p100H mutant mice than in WT mice at 14.5
dpc and 18.5 dpc (Figure 7A). However, at postnatal day 10.5,
we do not see circulating nucleated red cells in either WT or
mutant mice, suggesting that this may be a transient effect. In
addition, the mutant liver shows a significant increase in
hematopoietic precursor cells including nucleated erythro-
cytes at 18.5 dpc (Figure 7B). This alteration is noted as early
as 14.5 dpc. These observations suggest that besides silencing
the ey globin gene, Sox6 may affect red cell maturation.
Discussion
In this report, we show that Sox6 is a novel factor in the
complicated regulation mechanism of globin genes. In the
Sox6 null mouse, there is a transient effect on the embryonic
globin genes, f and bH1, and a persistent upregulation of the
ey globin gene. Sox6 directly regulates and binds to the
proximal promoter of ey gene and represses the ey-globin
gene in definitive erythropoiesis.
Sox6 belongs to group D of the Sox family of proteins that
includes Sox5, 12, 13, and 23 [34]. Group D Sox proteins
contain a coiled–coiled domain that mediates homo- and
Figure 5. In Situ Hybridization of ey and bmaj/min transcripts in WT and
p100H Mutant Mice at 14.5 dpc
Expression of ey globin (A–D) and b globin (E and F) in sagittal sections
of 14.5-dpc fetuses is shown in pseudocolor (red).
(A) WT fetus.
(B) p100H Homozygous mutant fetus.
(C and D) Inset boxes are shown. Prominent expression of ey globin is
only detected in the liver of mutant mice.
(E and F) In contrast, both WT and mutant mouse livers express adult
bmaj/min, respectively. No signals were detected above background
using sense probes (unpublished data).
The size bars represent 1 mm for (A) and (B); 100 lm for (C–F).
DOI: 10.1371/journal.pgen.0020014.g005
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heterodimerization [6,35]. Functionally, dimerization of Sox5
and Sox6 has been shown to greatly increase the binding
efficiency of the two Sox proteins to DNA that contains
adjacent Sox sites [6]. In addition, Sox6 binds more strongly
to an HMG-box dimer motif than to a single HMG-box motif
[5]. Therefore, it appears that target genes for group D Sox
proteins, such as Sox6, probably harbor pairs of HMG
binding sites with a configuration compatible with binding
of D-Sox protein dimers. Indeed, in the present study, the
defined Sox6 target sequence of the ey promoter contains two
Sox/Sox6 consensus sites (Figure 3A). Functionally, both sites
are essential for Sox6 binding to the ey promoter and
repression of its activity (Figure 3E and 3F). These observa-
tions suggest that Sox6 binds to this sequence of the ey
promoter either as a homodimer or as a heterodimer with
other Sox proteins. Because Sox proteins recognize a short 6-
bp core-binding sequence that allows for considerable
degeneracy, the specificity of their actions is thought to rely
upon interactions with other transcription factors [36]. In our
EMSAs, we had to run the electrophoresis on a 4%–6% gel
for at least 4–8 h to detect the Sox6-associated band,
suggesting that Sox6 is part of a high molecular weight
complex. A few other ey globin repressors have been reported
to bind to DNA sequences near the Sox/Sox6 consensus sites,
including the DRED complex [37] and COUP-TF [38]. Sox6
might interact with these factors and form a large repression
complex. Identification of other components of the Sox6-
containing complex associated with the ey promoter will shed
light on its mechanism of repression.
Sox proteins bind and bend linear DNA by partial
intercalation in the minor groove, and can also bind to
four-way junctions [2–4]. Therefore, one attractive model to
explain how Sox6 proteins control gene expression is that
they function as architectural factors bound to DNA,
influencing local chromatin structure by bending DNA and
by assembling multiprotein transcriptional complexes. By
changing the local chromatin structure, Sox6 could either
interfere with binding of other activators to the promoter or
facilitate binding of other repressors. Another example of a
repressor that interferes with an activator on the ey
Figure 6. Expression Pattern of Sox6 by Northern Blot and In Situ Assays
(A) Sox6 expression during embryonic development shown by Northern blot. Each lane contains 20 lg of total RNA from embryos whose ages are listed
above each lane as dpc. The filter was hybridized with a 32P-labeled 575-bp mouse Sox6 cDNA fragment (nucleotides 1353–1927). Numbers on the left
are sizes of standard marker fragments in kb.
(B) Sox6 expression shown by in situ hybridization. Panel i: Sagittal section through an E12.5 mouse embryo using antisense Sox6. mRNA distribution is
represented by pseudocolored red signal superimposed on the counterstained specimen. Sox6 transcripts are detected primarily in the fetal liver,
developing nervous system, chondrocytes and craniofacial area. Panel ii: The sense control probe shows no signal above background. Panel iii: E7.5
embryo hybridized to antisense probe for Sox6. No signal is detected above background specifically in blood islands (or with the sense probe,
unpublished data).
The size bars represent 100 lm.
DOI: 10.1371/journal.pgen.0020014.g006
PLoS Genetics | www.plosgenetics.org February 2006 | Volume 2 | Issue 2 | e140135
Sox6 Silence Epsilon Globin Expression
promoter is DRED. DRED interferes with EKLF, an activator,
in binding to the ey promoter [39]. Two HMG architectural
proteins (distantly related to the Sox family of transcription
factors), HMG-I and HMG-Y, were demonstrated to bind to
the human adult b globin silencers (silencers I and II) and
cause bending of the DNA, facilitating the binding of other
repressors [40].
Sox6 expression is temporally and spatially coincident with
definitive (but not primitive) erythropoiesis (Figure 6), and
Sox6 represses ey globin expression both in vivo (Figure 1)
and in vitro (Figure 2). Moreover, in situ hybridization clearly
shows that the persistent expression of ey globin in p100H
mutant mice is due to defects in the silencing mechanism of
definitive erythropoiesis that takes place in the liver (Figure
5). Taken together, these data demonstrate that Sox6
functions in definitive erythropoiesis to silence ey globin
expression.
The expression level of ey globin in homozygous Sox6 null
mice at 15.5 dpc and 18.5 dpc is statistically equivalent to
the level of bmaj/min expression in the livers of 15.5-dpc
and 18.5-dpc homozygous WT mice (Figure 1). This
demonstrates that ectopic expression of the ey globin gene
is quite robust in homozygous mutant mice. The expression
levels of two other embryonic globin genes (f and bh1) are
also higher in p100H homozygotes, compared with WT. Like
ey, levels of f and bh1 are dramatically higher in mutant
mice at 15.5 dpc. However, unlike ey globin, f and bh1
decline in expression by day 18.5 dpc (Figure 1), suggesting
that ey is regulated differently than f and bh1. It is possible
that Sox6 has a general effect on embryonic globin genes
(and erythrocyte maturation) in addition to a specific role in
silencing ey.
Although most p100H mutant mice die just after being
born, a rare few survive longer. None have been observed
to live longer than 2 wk after birth [14]. We examined a
single archived sample of liver RNA from a mutant mouse
on postnatal day 13.5 for globin gene expression and
detected high levels of ey globin in this RNA sample,
compared with undetectable ey RNA in WT control mice.
At this point in development, the levels of f and bh1 RNA
were undetectable both in mutant and WT; however, adult
b-like globin RNA levels were moderately elevated in the
mutant RNA compared with WT (unpublished data), similar
to what we observe at 18.5 dpc (Figure 1). These findings
suggest that Sox6 continues to function postnatally to
silence ey globin expression and has a unique function in
the regulation of ey-globin. The mechanism by which Sox6
regulates the other embryonic globin genes remains to be
elucidated.
Sox6 has other effects in erythropoiesis, including a delay
in enucleation/maturation in p100H mutant mice. This may be
the result of indirect effects, such as stress-induced prolifer-
ation (resulting from cardiac defects) and/or anemia. Severe
anemia can lead to rapid premature release of red cells, prior
Figure 7. The Blood and Liver Phenotype of WT and p100H Homozygous Mice
(A) Red blood cells of WT mice (left panels) and p100H homozygous mice (right panels) are shown at the indicated ages.
(B) Liver cells of WT mice (left panels) and p100H homozygous mice (right panels) are shown at the indicated ages.
DOI: 10.1371/journal.pgen.0020014.g007
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to their complete maturation. However, the hematocrit of
18.5-dpc mutant mice is only 20% lower than that of WT
(unpublished data), and this mild anemia is probably not
sufficient to explain the extent of nucleated red cells.
Alternatively, Sox6 itself may play a role in red cell terminal
differentiation, as it has been shown to be an important
factor in cardiac [15], neuronal [10], astrocytic [11], and
cartilage differentiation programs [32,41–44].
The restoration of normal enucleation of red cells in Sox6-
deficient mouse by postnatal day 10.5 may result from
functional compensation of other Sox proteins (expressed
at later developmental stages), since functional redundancy is
a recurring theme with Sox proteins [13,45,46]. Moreover,
erythropoiesis has already shifted from fetal liver to bone
marrow by postnatal day 10.5. The accompanying change in
the microenvironment of red cell production may permit
normal enucleation. Identification of Sox6 downstream
target genes and its interacting proteins will shed light on
the role of Sox6 in red cell terminal differentiation and the
enucleation process.
Recently, in vivo and in vitro analyses suggest that
reactivation of human e-globin would be therapeutically
beneficial to adults with sickle cell disease [47], providing a
rationale for detailed investigations into the molecular basis
of e-globin gene silencing. The present study identifies a
novel repressor, Sox6, which binds to the ey proximal
promoter, potentially as part of a larger repression complex.
Because murine Sox6 and its human counterpart are 94%
identical at the amino acid level [48], it is possible that human
Sox6 may also be important in human e globin silencing.
There is significant sequence homology between the human
and mouse e promoter regions, and the human promoter
contains at least two potential Sox6 binding sites. Indeed, the
existence of a silencer of the human e globin gene has been
proposed [49,50]. Thus, elucidation of the Sox6 repression
mechanism and identification of other components of the
Sox6-containing complex may further our understanding of e
globin regulation and potentially reveal additional molecular
targets for the treatment of sickle cell anemia and b
thalassemias.
Materials and Methods
Plasmid construction. The ey promoter deletion reporter plasmid
(E-luc) was generated by PCR amplification of the ey proximal
promoter. A 2.2-kb fragment upstream of the ey globin initiation
codon (ATG) was used, because it has been shown that all sequences
required for e gene silencing are located within a 3.7-kb EcoRI
fragment containing about 2 kb of sequence upstream of the e globin
gene cap site [50]. Nucleotide numbering is relative to the tran-
scription start site. The transcriptional start site is based on the
longest cDNA in the Fantom (Functional Annotation of Mouse)
database. The PCR primers contained XhoI and HindIII sites that
were used to clone the ey promoter fragment upstream of the firefly
luciferase gene in pGL3 Basic (Promega, Madison, Wisconsin, United
States). A 2.5-kb SstI/XhoI fragment of lLCRb 9.3 (micro LCR; [31])
was then inserted upstream of the ey promoter in the above pGL3
Basic plasmid, resulting in a reporter construct in which luciferase
expression is driven by the ey promoter. A series of deletion
constructs of the ey promoter were generated similarly. Forward
p r i m e r s w i t h a n X h o I s i t e i n c l u d e : MHB 1 4 5 7 ,
59CCGCTCGAGTGCTAGGCAAACACTCA39 (2077 to 2052);
MHB1503, 59CCGCTCGAGTCTCTACACTGTCACTCCCTG39 (634
to605); MHB1505, 59CCGCTCGAGGGAGCCAAAAAAAGAATGC39
(197 to 169); MHB1506, 59CCGCTCGAGCTGACCAATGGCTTC
AAAG39 (85 to58); MHB1532, 59CCGCTCGAGAATGCAGAACAA
AGGGTCAGA39 (63 to34); and MHB1507, 59CCGCTCGAGGTCTG
CGAAGAATAAAAGGC 39 (37 to9). All forward primers were used
in combination with the reverse primer HindIII site: MHB1477,
59CGGAAGCTTGGGAGGTTGCTGGTGA39 (þ45 toþ20).
Sox6-pcDNA3.1 [15] was used to overexpress Sox6. A truncated
version of the Sox6 overexpression construct (Sox6-DHMG-
pcDNA3.1) that lacks the HMG domain was generated, as described
by others [32]. Mutagenesis of Sox/Sox6 consensus binding sites of the
ey promoter were done by PCR. Forward primers used to generate
these mutagenized ey promoter reporter constructs include:
MHB1661, 59CCGCTCGAGAATGCAGTGCCAAGGGTCAGAACA
TTGTCTGCGAAG39 (63 to 19); MHB1662, 59CCGCTCGAGAA
TGCAGAACAAAGGGTCAGATGAGTGTCTGCGAAGAA39 (63 to
16); and MHB1663, 59CCGCTCGAGAATGCATGCCAAGGGTCAG
ATGAGTGTCTGCGAAGAA 39 (63 to 18).
Quantitation of globin mRNA. RNA was first reverse transcribed to
cDNA. Primers for cDNA PCR amplification of globin genes were
obtained from Primerbank [51]. All primers were searched against
the NCBI database to confirm specificity. For ey globin: MHB1666,
5 9TGGCCTGTGGAGTAAGGTCAA3 9; a n d MHB1 6 6 7 ,
59GAAGCAGAGGACAAGTTCCCA39. For f globin: MHB1668,
5 9CTACCCCCAGACGAAGACCTA3 9; a n d MHB1 6 6 9 ,
59CTTAACCGCATCCCCTACGG39. For bH1 globin: MHB1672,
5 9TGGACAACCTCAAGGAGACC 3 9; a n d MHB 1 6 7 3 ,
59ACCTCTGGGGTGAATTCCTT39. For bmaj/min globin: MHB1674:
5 9ATGGCCTGAATCACTTGGAC 3 9; a n d MHB 1 6 7 5 ,
59ACGATCATATTGCCCAGGAG39. Using the SYBR green supermix
kit with ROX (Bio-Rad, Hercules, California, United States), PCR
amplification was run on an ABI7000 (Applied Biosystems, Foster
City, California, United States) at the University of Arizona core
facility. All PCR was performed in a 25-ll reaction with 12.5 ll SYBR
green supermix. GAPDH mRNA levels were used as control for input
RNA. Standard curve analyses were performed to test the efficiency
of the amplifications. Triplicates were done for each PCR reaction.
Relative quantitative values were calculated in the ABI Prism 7000
SDS Software (Applied Biosystems) and normalized to GAPDH in
Microsoft Excel (Redmond, Washington, United States).
In situ hybridization. Antisense probes were designed to murine ey
globin nucleotides 509–584; bmaj globin nucleotides 458–549; and
mouse Sox6 nucleotides 1353–1927. Embryos were fixed overnight by
immersion in 4% paraformaldehyde, embedded in paraffin, sec-
tioned at 5 lm, and adhered to charge modified slides (VWR, West
Chester, Pennsylvania, United States). Slides were processed for in
situ hybridization as described [52] using in vitro transcribed RNA
probes labeled with 33P. Darkfield and brightfield images were
obtained with a Nikon Optiphot microscope (Nikon, Melville, New
York, United States) and SPOT RT-Slider digital camera (Diagnostic
Instruments, Sterling Heights, Michigan, United States). Objectives
used were 13 (NA¼ 0.04) and 103 (NA¼ 0.5). Images were processed,
pseudocolored, and combined using Photoshop (Adobe, San Jose,
California, United States) software with Fovea Pro (Reindeer
Graphics, Asheville, North Carolina, United States) plugins. Original
images are available.
Histology. 18.5-dpc embryos were exsanguinated and peripheral
blood smears were prepared from both mutant and WT mice. The
slides were Wright-stained and read by DAF. For whole mount
analysis, 14.5-dpc WT and mutant embryos, and postnatal day–10.5
mice were fixed in 10% formalin, paraffin-embedded, sectioned at 5
lm, and stained with hematoxylin and eosin. Liver samples (at 14.5
dpc and 18.5 dpc) were prepared in a similar manner. Images were
obtained with Nikon Labophot-2 microscope. Objectives used were E
Plan 40/0.65 160/0.17 Nikon (403 objective), E Plan 100/1.25 oil 160/
0.17 Nikon (1003 objective). The camera was a Nikon Coolpix 4300.
Original images are available.
Northern blot. A mouse embryonic tissue Northern blot filter
(Seegene, Rockville, Maryland, United States) was hybridized with a
Sox6 probe generated by RT-PCR (nucleotides 1353–1927) and
labeled with [a-32P]dCTP, by random primer labeling (RediprimeII;
Amersham Biosciences, Buckinghamshire, England, United King-
dom). The hybridization was performed in phosphate buffered 7%
SDS hybridization solution. Blots were washed with 0.23SSC, 1% SDS
at 60 8C prior to exposure to X-ray film (Kodak, Rochester, New York,
United States) at 80 8C for 6 d.
Cell culture and transfection. GM979 cells (Coriell Cell Reposito-
ries, Camden, New Jersey, United States) were cultured in Ham’s F12
with 2 mM L-glutamine supplemented with heat-inactivated 10%
fetal calf serum (Ivitrogen, Carlsbad, California, United States),
penicillin (100 units/ml), streptomycin 100 lg/ml), and L-glutamine
(2 mM). MEL cells were cultured in DMEM supplemented as above
(without heat inactivating the serum). GM979 cells (4 3 105) in log
phase of growth were transfected with plasmids by FuGENE6 (Roche,
PLoS Genetics | www.plosgenetics.org February 2006 | Volume 2 | Issue 2 | e140137
Sox6 Silence Epsilon Globin Expression
Indianapolis, Indiana, United States). Cells were transfected with ey
promoter reporter constructs (500 ng) along with either empty vector
or Sox6 overexpression vector (1000 ng). In assays of dosage effect, we
used 200 ng, 500 ng, and 1000 ng). pRL-CMV 15ng (Promega) was
used as a control for transfection efficiency.
Nuclear protein extract and in vitro translation of Sox6. Nuclear
extracts were prepared from MEL cells (2 3 107) using a kit (Active
Motif, Carlsbad, California, United States). The Sox6 in vitro
translation expression vector, tagged with c-Myc and HA, was
described before [15]. The translation was performed in a reticulo-
cyte lysate based in vitro translational system (TNTt Quick Coupled
Transcription/Translation Systems, Promega). A vector without the
Sox6 coding sequence was also translated as a negative control.
Antibodies. Sox6 antibodies used in this study were either kindly
provided by Dr. Enzo Lalli (Universite´ Louis Pasteur, France [7]) or
commercially obtained (Catalog No. sc-17332 X, Santa Cruz
Biotechnology, Santa Cruz, California, United States). All Sox6
antibodies generated similar results. c-Myc antibody was purchased
from Invitrogen. Normal rabbit IgG antibody was obtained from
Upstate Biotechnology (Lake Placid, New York, United States).
EMSA. Single-stranded complementary oligonucleotides were
annealed and end-labeled with [c-32P] ATP with T4 polynucleotide
kinase. EMSA was performed with 5 lg of nuclear proteins from MEL
cells or 3 ll of in vitro-translated Sox6 along with the reticulocyte
lysate in binding buffer: 100 mM NaCl, 10% glycerol, 200 ng/ll BSA,
50 ng/ll poly (dI-dC) or poly (dG-dC), 10 mM HEPES (pH 7), 0.1 mM
EDTA, 0.25 mM DTT, 0.6 mM MgCl2. For competition or supershift
assays, the indicated unlabelled oligonucleotide competitor (200-fold
molar excess) or antibody (3 ll) was added 30 min to 60 min prior to
addition of radiolabeled probe. Following addition of the radio-
labeled probe, the samples were incubated for 30 min or 60 min at
room temperature and loaded on a 4% or 6% (w/v) polyacrylamide
gel. Electrophoresis was performed at a constant 19 mAmp for 4–8 h
at room temperature, and the gels were dried prior to auto-
radiography. Antibodies used for supershift analyses included c-
Myc, HA, and Sox6 antibodies (described as above). The DNA
sequences of the oligonucleotides are as follows (only forward oligos
a r e l i s t e d ) : F o r t h e 3 6 - b p W T p r o b e :
59AATGCAGAACAAAGGGTCAGAACATTGTCTGCGAAG39
(MHB1556); for mutant probe 1 (M1): 59AACAAAGGGTC
AGAACATTGTCTGCGAAG39 (MHB1644); for mutant probe 2
(M2): 59AATGCAGAACAAAGGGTCAGAtgagTGTCTGCGAAG39
(MHB1648); for mutant probe 3 (M3): 59AATGCAGtgcc
AAGGGTCAGAACATTGTCTGCGAAG39 (MHB1650).
ChIP assay. As described by Nouzova [53], in brief: Cells from
MEL cells (4 3 107) or fetal liver cells from three 15.5-dpc WT mice
were treated with 1% formaldehyde for 10 min at 37 8C, rinsed in ice-
cold 13 Hanks’ balanced salt solution with 0.1% EDTA containing
protease inhibitors, collected by centrifugation at 4 8C, resuspended
in a SDS lysis buffer containing protease inhibitors, and incubated on
ice for 10 min. DNA-protein complexes were sonicated to 200 and
600 bp. One-tenth of the sample was set aside for input control, and
the remaining sample was precleared with protein A-Sepharose
(Amersham Biosciences, Piscataway, New Jersey, United States).
Following preclearing, the samples were split into thirds: one sample
treated with anti-Sox6, a second treated with normal rabbit IgG, and
the third sample without Ab. The last two were used as negative
controls. The chromatin-antibody complexes were eluted, and the
DNA protein cross-links were reversed with 5 M NaCl at 65 8C for 4 h.
Input DNA or immunoprecipitated DNA was used as a template in
the PCR reaction. PCR amplification of the ey promoter was
performed and yielded a 172-bp amplicon, corresponding to
nucleotides 31 to þ140 of the ey promoter (primers MHB1688,
5 9CGAAGAATAAAAGGCCACCA 3 9; a n d MHB 1 6 8 9 ,
59GCTTCACCACCAACCTCTTC39). PCR was performed under the
following conditions: 95 8C for 15 min followed by 30 cycles at 95 8C
for 30 s, 60 8C for 30 s, and 72 8C for 45 s, ending with a final extension
at 72 8C for 5 min.
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